SARS-CoV-2-IN-40

• UNSPSC Description:

  SARS-CoV-2-IN-40 (Compound 19) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-40 inhibits SARS-CoV-2 BA.1 and BA.5 variant infection of Calu3 lung cells, with IC50s of 100 nM and 160 nM respectively[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-in-40.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1C[C@H](C(CO)=C[C@]2(CCC[C@@H](CCCCCCCCCC)O2)O3)[C@H]3C=C1C

• Molecular Weight:

  404.58

• References & Citations:

  [1]Blagojevic P, et al. Synthetic Analogs of the Sponge Sesterterpenoid Alotaketal C are Potent Inhibitors of SARS-CoV-2 Omicron BA.1 and BA.5 Infections of Human Lung Cells. Org Lett. 2023 Jul 7;25(26):4825-4829.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2984557-53-9